Close Menu

NEW YORK – Luminex reported after the close of the market on Monday that its 2019 third quarter revenues were up 9 percent year over year.

For the quarter ended Sept. 30, the molecular diagnostics company reported revenues of $78.7 million compared to $72.4 million in the year-ago quarter, and missed the average Wall Street estimate for revenues of $81.8 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.